Minocycline + placebo
Phase 1/2Completed 0 views this week 0 watching💤 Quiet
Interest: 22/100
22
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Spinal Cord Injuries
Conditions
Spinal Cord Injuries
Trial Timeline
Jun 1, 2004 → Aug 1, 2010
NCT ID
NCT00559494About Minocycline + placebo
Minocycline + placebo is a phase 1/2 stage product being developed by Brain Biotech for Spinal Cord Injuries. The current trial status is completed. This product is registered under clinical trial identifier NCT00559494. Target conditions include Spinal Cord Injuries.
What happened to similar drugs?
7 of 20 similar drugs in Spinal Cord Injuries were approved
Approved (7) Terminated (1) Active (12)
Hype Score Breakdown
Clinical
9
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00559494 | Phase 1/2 | Completed |
Competing Products
20 competing products in Spinal Cord Injuries